Skin Cancer in Patients with Darker Skin Types

Overview / Definition Skin cancer encompasses a group of malignancies arising from the skin, with the most common types being basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. While incidence rates are lower in individuals with darker skin types (Fitzpatrick skin types IV-VI), these cancers can be more aggressive and are often diagnosed at a later stage due to delayed recognition. Understanding the nuances of skin cancer in patients with darker skin is crucial for effective management. Epidemiology Skin cancer is less common in individuals with darker skin, but the rates of diagnosis are increasing. The following points highlight key epidemiological aspects: Melanoma is the most significant concern, as it can occur in non-sun-exposed areas like the palms, soles, and mucous membranes. Studies show that while the incidence of BCC and SCC is lower, the mortality rates for melanoma in darker-skinned individuals are similar or higher than in lighter-skinned populations. In the United States, the incidence of melanoma in African Americans is about 1.3 per 100,000 compared to 22.7 per 100,000 in Caucasians. Pathophysiology / Mechanism The pathophysiology of skin cancer in darker skin types includes several factors: Melanin Production: Higher melanin levels provide some protection against UV radiation, but do not eliminate risk. Genetic Factors: Variations in genes related to pigmentation and DNA repair mechanisms influence cancer susceptibility. Chronic Inflammation: Conditions such as keloids and chronic dermatitis can predispose individuals to skin cancer. Clinical Presentation Skin cancer in darker-skinned individuals may present differently compared to those with lighter skin: Melanoma may appear as an atypical mole, often with irregular borders and color variation. Basal cell carcinoma often presents as a pearly papule or non-healing ulcer. Squamous cell carcinoma may manifest as a scaly plaque or a keratotic lesion. Patients may be less aware o